Podoplanin enhances lung cancer cell growth in vivo by inducing platelet aggregation
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Podoplanin enhances lung cancer cell growth in vivo by inducing platelet aggregation
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-06-16
DOI
10.1038/s41598-017-04324-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawal
- (2016) Monika Haemmerle et al. JOURNAL OF CLINICAL INVESTIGATION
- Unique intravascular tumor microenvironment predicting recurrence of lung squamous cell carcinoma
- (2015) Kakeru Hisakane et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Metastasis-promoting role of extravasated platelet activation in tumor
- (2015) Tomoharu Miyashita et al. JOURNAL OF SURGICAL RESEARCH
- Platelet adhesion to podoplanin under flow is mediated by the receptor CLEC-2 and stabilised by Src/Syk-dependent platelet signalling
- (2015) Alice Y. Pollitt et al. THROMBOSIS AND HAEMOSTASIS
- Platelets and cancer: a casual or causal relationship: revisited
- (2014) David G. Menter et al. CANCER AND METASTASIS REVIEWS
- Platelets promote osteosarcoma cell growth through activation of the platelet-derived growth factor receptor-Akt signaling axis
- (2014) Satoshi Takagi et al. CANCER SCIENCE
- Prognostic value of circulating tumor cells with podoplanin expression in patients with locally advanced or metastatic head and neck squamous cell carcinoma
- (2014) Jason Chia-Hsun Hsieh et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Platelets guide the formation of early metastatic niches
- (2014) M. Labelle et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical utility of erlotinib for the treatment of non-small-cell lung cancer in Japanese patients: current evidence
- (2014) Yosuke Togashi et al. Drug Design Development and Therapy
- Suppression of Aggrus/podoplanin-induced platelet aggregation and pulmonary metastasis by a single-chain antibody variable region fragment
- (2014) Kenichi Miyata et al. Cancer Medicine
- A novel and essential role for Fc RIIa in cancer cell-induced platelet activation
- (2013) A. Mitrugno et al. BLOOD
- Podoplanin is expressed at the invasive front of esophageal squamous cell carcinomas and is involved in collective cell invasion
- (2013) Yuichiro Nakashima et al. CANCER SCIENCE
- Expression of Aggrus/podoplanin in bladder cancer and its role in pulmonary metastasis
- (2013) Satoshi Takagi et al. INTERNATIONAL JOURNAL OF CANCER
- Platelets mediate lymphovenous hemostasis to maintain blood-lymphatic separation throughout life
- (2013) Paul R. Hess et al. JOURNAL OF CLINICAL INVESTIGATION
- Platelet receptors activated via mulitmerization: glycoprotein VI, GPIb-IX-V, and CLEC-2
- (2013) Y. Ozaki et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2
- (2013) Brett H. Herzog et al. NATURE
- Genome engineering using the CRISPR-Cas9 system
- (2013) F Ann Ran et al. Nature Protocols
- Ebp1 activates podoplanin expression and contributes to oral tumorigenesis
- (2013) Y Mei et al. ONCOGENE
- Platelets Promote Tumor Growth and Metastasis via Direct Interaction between Aggrus/Podoplanin and CLEC-2
- (2013) Satoshi Takagi et al. PLoS One
- The impact of Aggrus/podoplanin on platelet aggregation and tumour metastasis
- (2012) N. Fujita et al. JOURNAL OF BIOCHEMISTRY
- Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
- (2012) Rafael Rosell et al. LANCET ONCOLOGY
- Paraneoplastic Thrombocytosis in Ovarian Cancer
- (2012) Rebecca L. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Podoplanin promotes cell migration via the EGF-Src-Cas pathway in oral squamous cell carcinoma cell lines
- (2012) Harumi Inoue et al. Journal of Oral Science
- Podoplanin Is Regulated by AP-1 and Promotes Platelet Aggregation and Cell Migration in Osteosarcoma
- (2011) Akiko Kunita et al. AMERICAN JOURNAL OF PATHOLOGY
- Tumorigenic Role of Podoplanin in Esophageal Squamous-Cell Carcinoma
- (2010) Nur Rahadiani et al. ANNALS OF SURGICAL ONCOLOGY
- Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation
- (2010) P. Uhrin et al. BLOOD
- CLEC-2 activates Syk through dimerization
- (2010) C. E. Hughes et al. BLOOD
- Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling
- (2010) C. C. Bertozzi et al. BLOOD
- HGF Rescues Colorectal Cancer Cells from EGFR Inhibition via MET Activation
- (2010) D. Liska et al. CLINICAL CANCER RESEARCH
- The Platelet Receptor CLEC-2 Is Active as a Dimer
- (2009) Aleksandra A. Watson et al. BIOCHEMISTRY
- Podoplanin, a novel marker of tumor-initiating cells in human squamous cell carcinoma A431
- (2008) Naho Atsumi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started